Cargando…

Clinical Challenges in the Management of Malignant Ovarian Germ Cell Tumours

Nonepithelial ovarian cancers (NEOC) are a group of rare malignancies, including germ cell tumours (GCT) and sex cord-stromal tumours (SCST), along with small-cell carcinomas and sarcomas. GCTs represent 2–5% of ovarian cancers, with a yearly incidence of 4:100,000, and they usually affect young wom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saani, Iqra, Raj, Nitish, Sood, Raja, Ansari, Shahbaz, Mandviwala, Haider Abbas, Sanchez, Elisabet, Boussios, Stergios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298722/ https://www.ncbi.nlm.nih.gov/pubmed/37372675 http://dx.doi.org/10.3390/ijerph20126089

Ejemplares similares

A Case Report on an Adult Presentation of Henoch-Schönlein Purpura
por: Sood, Raja, et al.
Publicado: (2022)

Systemic anti-cancer treatment in malignant ovarian germ cell tumours (MOGCTs): current management and promising approaches
por: Uccello, Mario, et al.
Publicado: (2020)

Amyand’s Hernia: A Radiological Solution of a Surgical Dilemma
por: Raj, Nitish, et al.
Publicado: (2023)

Malignant ovarian mixed germ cell tumour: a rare combination
por: Koshy, M, et al.
Publicado: (2005)

Recent Insights into PARP and Immuno-Checkpoint Inhibitors in Epithelial Ovarian Cancer
por: Revythis, Antonios, et al.
Publicado: (2022)

Ovarian cancer: state of the art and perspectives of clinical research
por: Boussios, Stergios, et al.
Publicado: (2020)

A review on pregnancy complicated by ovarian epithelial and non-epithelial malignant tumors: Diagnostic and therapeutic perspectives
por: Boussios, Stergios, et al.
Publicado: (2018)

BRCA Mutations in Ovarian and Prostate Cancer: Bench to Bedside
por: Boussios, Stergios, et al.
Publicado: (2022)

Clonal diversification and histogenesis of malignant germ cell tumours
por: Oliver, Thomas R. W., et al.
Publicado: (2022)

Metformin and ovarian cancer: the evidence
por: Urpilainen, Elina, et al.
Publicado: (2020)

Hereditary Ovarian Cancer: Towards a Cost-Effective Prevention Strategy
por: Ghose, Aruni, et al.
Publicado: (2022)

Hallmarks of the Tumour Microenvironment of Gliomas and Its Interaction with Emerging Immunotherapy Modalities
por: Linares, Christian A., et al.
Publicado: (2023)

Current and future immunotherapy approaches in ovarian cancer
por: Demircan, Nazım Can, et al.
Publicado: (2020)

Prognosis of lymphadenectomy in malignant ovarian germ cell tumor
por: Lv, Bin, et al.
Publicado: (2023)

Epithelial Ovarian Cancer: Providing Evidence of Predisposition Genes
por: Shah, Sidrah, et al.
Publicado: (2022)

N-cadherin expression in malignant germ cell tumours of the testis
por: Bremmer, Felix, et al.
Publicado: (2012)

Bleomycin-Induced Flagellate Erythema in a Patient Diagnosed with Ovarian Yolk Sac Tumor
por: Boussios, Stergios, et al.
Publicado: (2015)

Swyer's Syndrome with Mixed Ovarian Malignant Germ Cell Tumor and Ovarian Gonadoblastoma
por: Zhu, Hong-Lan, et al.
Publicado: (2016)

NOTCH signalling in ovarian cancer angiogenesis
por: Perez-Fidalgo, Jose Alejandro, et al.
Publicado: (2020)

Malignant germ cell tumours of childhood: new associations of genomic imbalance
por: Palmer, R D, et al.
Publicado: (2007)

GERM CELL TUMOURS
Publicado: (1984)

GERM CELL TUMOURS
Publicado: (1982)

Incidence and Survival Rates for Female Malignant Germ Cell Tumors: An Institutional Review
por: Saeed Usmani, Afshan, et al.
Publicado: (2022)

Therapeutic Challenges for Cisplatin-Resistant Ovarian Germ Cell Tumors
por: De Giorgi, Ugo, et al.
Publicado: (2019)

Glutathione S-transferase activity and isoenzyme composition in benign ovarian tumours, untreated malignant ovarian tumours, and malignant ovarian tumours after platinum/cyclophosphamide chemotherapy.
por: van der Zee, A. G., et al.
Publicado: (1992)

Ovarian germ cell malignancies in England: epidemiological parallels with testicular cancer.
por: dos Santos Silva, I., et al.
Publicado: (1991)

Advancing clinical and translational research in germ cell tumours (GCT): recommendations from the Malignant Germ Cell International Consortium
por: Fonseca, Adriana, et al.
Publicado: (2022)

Renal function related to different treatment modalities for malignant germ cell tumours.
por: Aass, N., et al.
Publicado: (1990)

A possible rising incidence of malignant germ cell tumours in young women.
por: Walker, A. H., et al.
Publicado: (1984)

'JEB'--a carboplatin based regimen for malignant germ cell tumours in children.
por: Pinkerton, C. R., et al.
Publicado: (1990)

Malignant mixed germ cell tumour of ovary- an unusual combination and review of literature
por: Goyal, Lajya Devi, et al.
Publicado: (2014)

Non-Epithelial Ovarian Cancers: How Much Do We Really Know?
por: Cheung, Alison, et al.
Publicado: (2022)

The Experience of a Single NHS England Trust on the Impact of the COVID-19 Pandemic on Junior and Middle-Grade Doctors: What Is Next?
por: Revythis, Antonios, et al.
Publicado: (2021)

COVID-19, Mucormycosis and Cancer: The Triple Threat—Hypothesis or Reality?
por: Mahajan, Ishika, et al.
Publicado: (2022)

PARP Inhibitors in Ovarian Cancer: The Route to “Ithaca”
por: Boussios, Stergios, et al.
Publicado: (2019)

Molecular Pathways and Targeted Therapies for Malignant Ovarian Germ Cell Tumors and Sex Cord–Stromal Tumors: A Contemporary Review
por: Maoz, Asaf, et al.
Publicado: (2020)

Germ cell tumour chemotherapy.
por: Horwich, A.
Publicado: (1989)

Applications of Proteomics in Ovarian Cancer: Dawn of a New Era
por: Ghose, Aruni, et al.
Publicado: (2022)

Increased mortality rates in young and middle-aged patients with malignant germ cell tumours
por: Fosså, S D, et al.
Publicado: (2004)

Prognostic impact of lymphadenectomy in clinically early stage malignant germ cell tumour of the ovary
por: Mahdi, H, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_k7m470l11g3km7ct23h77gu27q